Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) — Financial Flexibility Index
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥60.95 Million (operating CF CN¥55.69 Million minus capex CN¥5.26 Million) represents 0% of total liabilities (CN¥362.71 Million). Check asset allocation strategy of Zhejiang Cheng Yi Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Cheng Yi Pharmaceutical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Zhejiang Cheng Yi Pharmaceutical Co Ltd across 15 annual periods. See Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Cheng Yi Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Cheng Yi Pharmaceutical Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.07x | CN¥325.79 Million | CN¥280.39 Million | CN¥304.55 Million | ▲ +86.6% |
| 2024 | 0.57x | CN¥265.60 Million | CN¥205.72 Million | CN¥463.31 Million | ▲ +50.2% |
| 2023 | 0.38x | CN¥265.63 Million | CN¥194.78 Million | CN¥696.15 Million | ▼ -42.8% |
| 2022 | 0.67x | CN¥418.79 Million | CN¥165.94 Million | CN¥628.16 Million | ▼ -22.3% |
| 2021 | 0.86x | CN¥277.60 Million | CN¥143.49 Million | CN¥323.62 Million | ▼ -14.4% |
| 2020 | 1.00x | CN¥321.48 Million | CN¥177.81 Million | CN¥320.79 Million | ▼ -42.0% |
| 2019 | 1.73x | CN¥364.82 Million | CN¥181.01 Million | CN¥211.29 Million | ▼ -39.4% |
| 2018 | 2.85x | CN¥405.82 Million | CN¥134.30 Million | CN¥142.45 Million | ▲ +99.7% |
| 2017 | 1.43x | CN¥104.75 Million | CN¥66.75 Million | CN¥73.41 Million | ▲ +2.8% |
| 2016 | 1.39x | CN¥116.71 Million | CN¥95.08 Million | CN¥84.11 Million | ▲ +21.2% |
| 2015 | 1.15x | CN¥98.73 Million | CN¥81.94 Million | CN¥86.21 Million | ▼ -13.1% |
| 2014 | 1.32x | CN¥109.12 Million | CN¥84.11 Million | CN¥82.77 Million | ▲ +143.3% |
| 2013 | 0.54x | CN¥71.76 Million | CN¥48.19 Million | CN¥132.43 Million | ▲ +74.1% |
| 2012 | 0.31x | CN¥56.01 Million | CN¥37.96 Million | CN¥179.99 Million | ▲ +152.2% |
| 2011 | 0.12x | CN¥23.82 Million | CN¥10.04 Million | CN¥193.09 Million | — |